The collaboration between Muscular Dystrophy UK, the leading charity for over 110,000 people in the UK living with one of ...
The 11-year-old's strength and bravery in living with the impact of the serious muscle-wasting condition was hailed by her ...
The startup is using CRISPR tools to stop errant expression of a gene linked to facioscapulohumeral muscular dystrophy, a disorder on the radars of several drugmakers.
The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.
4 天on MSN
Convener of Stirling Council’s Children and Young People Committee, Cllr Danny Gibson said: “Somhairle’s bravery, inner strength and positivity in the face of this serious condition has had a major ...
When Lauren Clarke was 14, she was diagnosed with a rare, incurable muscle-weakening disorder. Ten years on, she has become ...
Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic ...
Patients with myotonic dystrophy face unique challenges in managing their ... 1-2 Recent studies presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference shed ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果